Over two-thirds of U.S. physicians have a positive attitude toward electronic promotion by pharmaceutical companies, and nearly three-fourths (73%) say they think ePromotion is equal or superior to face-to-face communication from drug sales reps, according to an annual study on ePromotion from SDI.